Biogen, Inc. (NQ: BIIB )

338.00 USD +6.30 (+1.90%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 3, 2021 Add to My Watchlist

Price and Volume

Volume	1,326,650
Open	331.81
Bid (Size)	326.00 (1)
Ask (Size)	339.80 (1)
Prev. Close	331.70
Today's Range	325.09 - 338.36
52wk Range	223.25 - 468.55
Shares Outstanding	149,033,443
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Biogen Announces Results from Phase 3b NOVA Study Evaluating Every Six-Week Dosing with Natalizumab in Relapsing-Remitting Multiple Sclerosis

August 02, 2021

Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer's Disease at AAIC 2021

July 30, 2021

Performance

YTD	+39.12%	+39.12%
1 Month	-2.00%	-2.00%
3 Month	+24.71%	+24.71%
6 Month	+21.71%	+21.71%
1 Year	+21.51%	+21.51%

More News

Late-Breaking AAIC Presentation Explores Potential Clinical Effects Of Lecanemab (BAN2401)

July 29, 2021

Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer’s Disease at AAIC 2021

July 29, 2021

Analyst Ratings for Biogen

August 02, 2021

Analysts Anticipate PJP To Hit $94

August 02, 2021

Top Biotech Stocks To Watch After Bristol Myers’ Opdivo Sees Q2 Growth

July 28, 2021

Biogen Getting Closer To Key Technical Measure

Today 3:00 EDT

Biogen: Does Aduhelm Make it the Next Dendreon?

July 30, 2021

Will Biogen Be Able to Move Past the Drama Surrounding Its Alzheimer's Disease Drug?

July 31, 2021

Is Now a Good Time to Buy Biogen Stock?

July 30, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search form

The Daily Times Leader

Biogen, Inc. (NQ: BIIB )

Price and Volume

Top News

Performance

More News